Back to TWO SIGMA INVESTMENTS, LP TWO SIGMA INVESTMENTS, LP

VKTXVKTX

Showing 8 of 27 quarters

Position history for TWO SIGMA INVESTMENTS, LPTWO SIGMA INVESTMENTS, LP's holdings in VIKING THERAPEUTICS INC

Yes. Two Sigma Investments holds 3,937,414 shares of VKTX (Viking Therapeutics), worth $153.6M, as of its Q2 2026 13F filing. It reduced the position by 494,728 shares (-11.2%) from Q1 2026. Two Sigma Investments has held VKTX since Q1 2025, across 6 quarterly 13F filings. VKTX is 0.1% of Two Sigma Investments' reported 13F portfolio.

Current Value

$153.6M

Current Shares

3.9M

Total Value Change

+$150.3M

Total Shares Change

+3.9M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
3.9M
-11.2%
$153.6M0.1%$39.01
0
2026-Q1
Increased
4.4M
+82.0%
$144.2M0.1%$32.54
56
2025-Q4
Increased
2.4M
+16.8%
$85.7M0.1%$35.18
41
2025-Q3
Increased
2.1M
+58.7%
$54.8M0.1%$26.28
42
2025-Q2
Increased
1.3M
+2406.6%
$34.8M0.1%$26.50
47
2025-Q1
New
52,414
—
$1.3M0.0%$24.15
35
2024-Q4
Exited
0
-100.0%
$00.0%$40.24
0
2024-Q3
Decreased
51,546
-4.0%
$3.3M0.0%$63.31
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used